文献速递肺外科

机器人辅助与电视辅助胸腔镜及开胸肺叶切除术的医院成本与临床效果:倾向评分加权比较

Hospital cost and clinical effectiveness of robotic-assisted versus video-assisted thoracoscopic and open lobectomy: A propensity score-weighted comparison.
PubMed 文献 · J Thorac Cardiovasc Surg · 2019-01-23

该单中心回顾性研究纳入2012至2017年697例肺叶切除术患者,采用倾向评分逆概率加权比较机器人、VATS与开胸三种术式的成本和围术期结局。结果显示开胸手术手术室时间最短、手术室成本最低,但机器人与VATS住院时间更短、肺不张和肺炎事件更少;三组总住院直接成本、间接成本和收费无显著差异。

要点

  • 机器人与VATS肺叶切除术的总住院成本与开胸相当,但临床效果更优。
  • 开胸手术手术室时间最短且手术室成本最低。
  • 微创手术增加的操作成本可被术后恢复改善和住院缩短所抵消。

核心结论

  • 机器人与VATS肺叶切除术成本相似,且临床效果优于开胸手术。
  • 微创肺叶切除术增加的操作成本可通过术后成本降低和住院缩短回收。

研究设计与样本

  • 单中心回顾性研究,纳入2012至2017年697例肺叶切除术患者。
  • 采用倾向评分逆概率加权(IPTW)平衡基线特征,比较机器人(n=296)、VATS(n=161)和开胸(n=240)三组。

主要发现

  • 开胸组手术室时间最短:机器人278分钟 vs VATS 298分钟 vs 开胸265分钟,P=.05。
  • 开胸组手术室成本最低:机器人$9,912 vs VATS $9,491 vs 开胸$8,698,P=.001。
  • 机器人和VATS组住院时间显著短于开胸组:机器人3.8天 vs VATS 3.8天 vs 开胸5.4天,P<.001。
  • 机器人和VATS组肺不张和肺炎事件显著少于开胸组。
  • IPTW调整后总住院直接成本无显著差异:机器人$17,223 vs VATS $17,260 vs 开胸$18,075,P=.48;间接成本和收费亦无显著差异。

临床怎么用

  • 机器人或VATS肺叶切除术可作为开胸手术的替代选择,总住院成本相当且临床效果更优。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare cost and perioperative outcomes of robotic, video-assisted thoracoscopic surgery (VATS), and open surgical approaches to pulmonary lobectomy. METHODS: Patients who underwent pulmonary lobectomy between 2012 and 2017 at a single tertiary referral center were reviewed. Propensity score adjustment by inverse probability of treatment weighting (IPTW) was used to balance baseline patient characteristics. The primary outcomes of the study were direct hospital cost and perioperative outcomes, including operative time, complications rates, and length of stay. Indirect cost and charges were secondary financial outcomes. RESULTS: A total of 697 patients underwent pulmonary lobectomy by robotic (n = 296), VATS (n = 161), and open thoracotomy (n = 240). In the IPTW-adjusted analysis, open thoracotomy had the shortest mean operating room time (robotic 278 minutes vs VATS 298 minutes vs open 265 minutes, P = .05), and lowest operating room costs (robotic $9,912 vs VATS $9491 vs open $8698, P = .001). Length of stay was significantly shorter after robotic and VATS lobectomy (robotic 3.8 days vs VATS 3.8 days vs open 5.4 days, P < .001), with significantly fewer events of atelectasis and pneumonia as compared with the open group. In sum, no significant differences were seen in IPTW-adjusted direct cost (robotic $17,223 vs VATS $17,260 vs open $18,075, P = .48), indirect cost, or charges for the total hospital stay. CONCLUSIONS: Robotic and VATS lobectomy were associated with similar cost and improved clinical effectiveness as compared with the open thoracotomy approach. Increased procedural cost of minimally invasive lobectomy can be recovered by postoperative costs reductions, associated with improved postoperative outcomes and shorter hospital stay.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Kneuertz PJ, Singer E, D'Souza DM, et al. Hospital cost and clinical effectiveness of robotic-assisted versus video-assisted thoracoscopic and open lobectomy: A propensity score-weighted comparison. J Thorac Cardiovasc Surg. 2019. PMID: 30819575. doi:10.1016/j.jtcvs.2018.12.101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。